Literature DB >> 1312622

Random mutagenesis of the thymidine kinase gene of varicella-zoster virus.

T Suzutani1, S F Lacey, K L Powell, D J Purifoy, R W Honess.   

Abstract

To understand the relationship between the primary structure and function of varicella-zoster virus thymidine kinase (VZV TK; EC 2.7.1.21), we established rapid screening and phenotypic selection of mutant VZV TK genes in TK-deficient Escherichia coli C600 by using a constitutive pKK223-3 expression plasmid. In this screening system, mutant TK genes generated by random mutagenesis were identified by the sensitivity of E. coli-expressing VZV TKs to 5-bromo-2'-deoxyuridine and 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl) uracil. Twenty-four mutant clones with amino acid substitutions were isolated, and their nucleotide sequence and enzymatic activities were determined. Of the 24 clones, 20 had single amino acid substitutions, 2 clones had double amino acid substitutions, and 1 clone had triple amino acid substitutions. In 17 cases of single amino acid substitution, six mutations led to lost enzyme activity, and four of these six mutations centered in the ATP-binding site. The other 11 mutations resulted in reduction of both TK and thymidylate kinase activities or only thymidylate kinase activity and were located in scattered positions in the VZV TK gene, although 5 mutations showed a tendency to cluster in the region between positions 251 and 260.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312622      PMCID: PMC289003     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  [An uncommon form of thymidine kinase in breast cancers].

Authors:  A Madec-Baron; G Baron; S Sampérez; P Jouan
Journal:  C R Acad Sci III       Date:  1989

Review 2.  Thymidine kinase.

Authors:  S Kit
Journal:  Microbiol Sci       Date:  1985-12

3.  E. coli F1-ATPase: site-directed mutagenesis of the beta-subunit.

Authors:  D Parsonage; S Wilke-Mounts; A E Senior
Journal:  FEBS Lett       Date:  1988-05-09       Impact factor: 4.124

4.  Sequence analyses of herpesviral enzymes suggest an ancient origin for human sexual behavior.

Authors:  G A Gentry; M Lowe; G Alford; R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

5.  An optimized thymidylate kinase assay, based on enzymatically synthesized 5-[125I]iododeoxyuridine monophosphate and its application to an immunological study of herpes simplex virus thymidine-thymidylate kinases.

Authors:  A R Karlström; J S Gronowitz
Journal:  Anal Biochem       Date:  1987-05-01       Impact factor: 3.365

6.  Comparison of susceptibilities of varicella-zoster virus and herpes simplex viruses to nucleoside analogs.

Authors:  H Machida
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

7.  Evolution of the herpes thymidine kinase: identification and comparison of the equine herpesvirus 1 thymidine kinase gene reveals similarity to a cell-encoded thymidylate kinase.

Authors:  G R Robertson; J M Whalley
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

8.  Molecular analysis of the pyrimidine deoxyribonucleoside kinase gene of wild-type and acyclovir-resistant strains of varicella-zoster virus.

Authors:  M H Sawyer; G Inchauspe; K K Biron; D J Waters; S E Straus; J M Ostrove
Journal:  J Gen Virol       Date:  1988-10       Impact factor: 3.891

9.  ATP-binding site of adenylate kinase: mechanistic implications of its homology with ras-encoded p21, F1-ATPase, and other nucleotide-binding proteins.

Authors:  D C Fry; S A Kuby; A S Mildvan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

10.  NMR studies of the MgATP binding site of adenylate kinase and of a 45-residue peptide fragment of the enzyme.

Authors:  D C Fry; S A Kuby; A S Mildvan
Journal:  Biochemistry       Date:  1985-08-13       Impact factor: 3.162

View more
  9 in total

1.  Selection and characterization of varicella-zoster virus variants resistant to (R)-9-[4-hydroxy-2-(hydroxymethy)butyl]guanine.

Authors:  T I Ng; Y Shi; H J Huffaker; W Kati; Y Liu; C M Chen; Z Lin; C Maring; W E Kohlbrenner; A Molla
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Phenotypic and genetic characterization of thymidine kinase from clinical strains of varicella-zoster virus resistant to acyclovir.

Authors:  F Morfin; D Thouvenot; M De Turenne-Tessier; B Lina; M Aymard; T Ooka
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

3.  Identification and analysis of the simian varicella virus thymidine kinase gene.

Authors:  C Y Pumphrey; W L Gray
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

4.  A rapid phenotypic assay for detection of acyclovir-resistant varicella-zoster virus with mutations in the thymidine kinase open reading frame.

Authors:  R Sahli; G Andrei; C Estrade; R Snoeck; P R Meylan
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

5.  Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes.

Authors:  S Koyano; T Suzutani; I Yoshida; M Azuma
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

6.  Activity and mechanism of action of HDVD, a novel pyrimidine nucleoside derivative with high levels of selectivity and potency against gammaherpesviruses.

Authors:  N Coen; U Singh; V Vuyyuru; J J Van den Oord; J Balzarini; S Duraffour; R Snoeck; Y C Cheng; C K Chu; G Andrei
Journal:  J Virol       Date:  2013-01-23       Impact factor: 5.103

7.  Uneven genetic robustness of HIV-1 integrase.

Authors:  Suzannah J Rihn; Joseph Hughes; Sam J Wilson; Paul D Bieniasz
Journal:  J Virol       Date:  2014-10-22       Impact factor: 5.103

Review 8.  Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment.

Authors:  R Snoeck; G Andrei; E De Clercq
Journal:  Drugs       Date:  1999-02       Impact factor: 11.431

9.  Extreme genetic fragility of the HIV-1 capsid.

Authors:  Suzannah J Rihn; Sam J Wilson; Nick J Loman; Mudathir Alim; Saskia E Bakker; David Bhella; Robert J Gifford; Frazer J Rixon; Paul D Bieniasz
Journal:  PLoS Pathog       Date:  2013-06-20       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.